Fighting new wars with old Weapons: Repurposing of Anti-Malarial drug for Anticancer Therapy
محل انتشار: فصلنامه سرطان پستان، دوره: 9، شماره: 4
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 34
فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHB-9-4_012
تاریخ نمایه سازی: 14 آذر 1402
چکیده مقاله:
Background: Quinacrine (QC), an attractive anticancer drug, has been forwarded for clinical evaluation in various cancer types due to its tremendous safety data accumulated since World War II. Its shotgun nature makes it unmissable as a chemotherapy drug that traps and activates multiple pathways.
Results: Recently, QC has been shown to block malignancy by affecting pathways, including RHO signaling, G۱/S arrest, ROS emission, and cell death through autophagy. In this review, we have extensively studied QC as an anticancer agent that affects various signaling pathways. We have documented activity via WNT, NOTCH, HEDGEHOG, MAPK, EGFR, P۵۳, RHO, AKT, NF-k and TGF pathways and reformed the already established mode of action of QC.
Conclusion: QC’s effects on multiple key signaling pathways, implicated in the malignant progression of numerous cancer types, make it an exciting candidate as a chemotherapeutic agent for new combination treatments and therapies.
نویسندگان
Angela Samanta
CMBL, Department of Biological Sciences, BITS Pilani K K Birla Goa Campus, Zuarinagar, Goa ۴۰۳۷۲۶, India
Angshuman Sakar
CMBL, Department of Biological Sciences, BITS Pilani K K Birla Goa Campus, Zuarinagar, Goa ۴۰۳۷۲۶, India